Zhiling Qu
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
-
- Atherosclerosis and Cardiovascular Diseases
- Immune cells in cancer
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- RNA Interference and Gene Delivery 2
- Congenital heart defects research 2
- Advanced biosensing and bioanalysis techniques 1
- Oncology 8
- Chemokine receptors and signaling 4
- Cancer Cells and Metastasis 3
- Co-authors
- Qiurong Ruan (12 shared papers)Jun Yu (6 shared papers)Dan Yan (2 shared papers)Juan Ni (1 shared paper)Guoping Wang (1 shared paper)Yan Li (4 shared papers)Dujuan Li (4 shared papers)Dan Yan (3 shared papers)
- Journals
- Experimental and Molecular Pathology (2 papers)International Journal of Cardiology (1 paper)Biotechnology Letters (1 paper)Atherosclerosis (1 paper)International Journal of Experimental Pathology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhiling Qu
20 papers receiving 378 citations
Peers
Comparison fields: 5 of 68
- Genetics 89
- Immunology 119
- Complementary and alternative medicine 32
- Cancer Research 57
- Immunology and Allergy 21
Countries citing papers authored by Zhiling Qu
This map shows the geographic impact of Zhiling Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiling Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiling Qu more than expected).
Fields of papers citing papers by Zhiling Qu
This network shows the impact of papers produced by Zhiling Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiling Qu. The network helps show where Zhiling Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhiling Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 94 | |
| 2 | 1997 | 59 | |
| 3 | 2016 | 41 | |
| 4 | 2009 | 31 | |
| 5 | 2009 | 27 | |
| 6 | 2014 | 25 | |
| 7 | 2011 | 21 | |
| 8 | 2011 | 19 | |
| 9 | 2010 | 12 | |
| 10 | 2011 | 12 | |
| 11 | Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells. | 2007 | 12 |
| 12 | 2014 | 5 | |
| 13 | 2015 | 4 | |
| 14 | 2012 | 4 | |
| 15 | 2016 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2003 | 3 | |
| 18 | 2022 | 2 | |
| 19 | [Effects of oxidized low density lipoprotein and very low density lipoprotein on the expression of MCP-1 by monocytes]. | 1996 | 1 |
| 20 | 2004 | 1 |
About Zhiling Qu
Zhiling Qu is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Surgery, having authored 21 papers that have together received 380 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Chemokine receptors and signaling (4 papers), Mesenchymal stem cell research (3 papers), Cancer Cells and Metastasis (3 papers), Cancer, Lipids, and Metabolism (2 papers), RNA Interference and Gene Delivery (2 papers), Congenital heart defects research (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Genetics (89 citations), Immunology (119 citations), Complementary and alternative medicine (32 citations), Cancer Research (57 citations) and Immunology and Allergy (21 citations). Zhiling Qu has collaborated with scholars based in China and United States. Frequent co-authors include Qiurong Ruan, Jun Yu, Dan Yan, Juan Ni, Guoping Wang, Yan Li, Dujuan Li, Dan Yan, Sheng Zhou and Xiaoyan Wang. Their work appears in journals such as Experimental and Molecular Pathology, International Journal of Cardiology, Biotechnology Letters, Atherosclerosis and International Journal of Experimental Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.